Callan Family Office »

Nautilus Biotechnology shares owned by Callan Family Office

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 15k 0.84
2025-06-30 $35k 49k 0.72

More positions owned by Callan Family Office

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)
Eli Lilly & Co. (LLY)

View all positions for Callan Family Office

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Comprehensive Financial Management
Amazon
Clarius
Renaissance Technologies
Millennium Management
Tikvah Management
Geode Capital Management
Dimensional Fund Advisors
CI Private Wealth
Jacobs Levy Equity Management

View all funds holding Nautilus Biotechnology